Leading reproductive and developmental biologists will gather in Boston for the 2026 Activated Egg Symposium, a one-day meeting focused on how human eggs activate and initiate early embryonic development. The event, titled “Unique Human Egg Activation Pathways,” is part of a series hosted by the Bedford Research Foundation since 2002 and aims to foster scientific exchange and collaboration across academia, fertility clinics, and biotechnology.
The symposium will feature presentations on ovarian biology, fertilization, calcium signaling, genome stability, cellular reprogramming, stem cell-based models of early development, and the biological foundations of successful embryo development. By bringing together experts from diverse disciplines, the meeting seeks to accelerate translational progress in fertility and developmental science.
“We still have fundamental questions about how human eggs develop, and answering them could open new possibilities in reproductive and regenerative medicine,” said Ann A. Kiessling, Director of the Bedford Research Foundation. The symposium’s focus on egg activation is particularly significant because it addresses a critical juncture in reproduction: the moment an egg becomes capable of supporting embryonic development. Understanding these mechanisms could lead to improved fertility treatments, better outcomes for assisted reproduction, and advances in stem cell science.
The speaker lineup includes Evelyn Telfer, Professor and Chair of Reproductive Biology at the University of Edinburgh; Ali H. Brivanlou of The Rockefeller University; Rafael Fissore of the University of Massachusetts Amherst; Ehsan Habibi of the Ottawa Hospital Research Institute and University of Ottawa; Jonathan van Blerkom of the University of Colorado, Boulder; Dietrich M. Egli of Columbia University Irving Medical Center; and Elizebeth Carr, America’s first IVF baby, who will speak as an advocate. Their collective expertise spans ovarian biology, fertilization, nuclear transfer, pluripotency, synthetic embryology, and genome stability in early development.
The symposium’s cross-sector format is designed to promote dialogue and new partnerships among researchers, clinicians, trainees, and innovators. Organizers emphasize the translational relevance of the topics, noting that discoveries in egg activation have direct implications for fertility treatment, assisted reproduction, stem cell science, and developmental medicine. The one-day intensive program is structured to maximize scientific exchange and audience engagement.
As reproductive science continues to evolve, forums like this symposium provide a rare opportunity to hear directly from scientists shaping the field. The discussions could inform future research directions and clinical practices, ultimately impacting how infertility is treated and how regenerative medicine harnesses cellular reprogramming. The Bedford Research Foundation, supported by the ESHE Fund, collaborates with leading institutions to address critical challenges in human health, and this symposium underscores its commitment to advancing biomedical research in reproductive biology and stem cell technologies.
